Showing 1672 results
-
Story /Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.
-
Story /Inspired by her mother, Vicky Qi leads drug discovery teams.
-
Story /Read how NIBR and Dana-Farber scientists aim to expand immunotherapy options for patients
-
Story /The most lethal strain could be eliminated by 2030, but major hurdles remain.
-
Story /Ogimi in Okinawa, Japan has the highest percentage of centenarians in the world, making it a curiosity for those eager to learn more about the secrets of aging.
-
Press release /Sandoz and Austrian government announce joint plans to drive long-term competitiveness of European production for key antibiotics in Europe Planned combined investment of more than EUR 150…
-
Press release /Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate…
-
Story /Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.
-
Press release /Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in…
-
Story /Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.